
Akers Biosciences, Inc. AKER
Country |
|
IPO year |
2014 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
306 K |
Market Cap[1] |
$ 20.6 M |
EBITDA (LTM) |
$ -222 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.9 | 9.0 % | $ 26.4 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 31.07 | -1.26 % | $ 1.48 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.93 | -1.73 % | $ 16.3 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 84.0 | 1.13 % | $ 40.4 B | NYSE | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 19.1 | 0.45 % | $ 9.8 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 115.62 | -1.86 % | $ 5.6 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 64.55 | -1.59 % | $ 3.25 B | NYSE,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 127.87 | 1.61 % | $ 4.09 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.58 | 2.14 % | $ 24.6 M | Nasdaq Global Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 171.22 | -1.8 % | $ 49.3 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.88 | 2.2 % | $ 223 M | Nasdaq Capital Market | ||
|
AngioDynamics
ANGO
|
$ 10.98 | -0.54 % | $ 449 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 106.91 | -0.87 % | $ 2.42 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 175.43 | 0.04 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.47 | 3.28 % | $ 25.2 M | Nasdaq Global Select Market | ||
|
BioLife Solutions
BLFS
|
$ 20.59 | 2.06 % | $ 949 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 3.92 | 1.29 % | $ 40.7 M | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 7.9 | 3.81 % | $ 43.6 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 28.51 | -0.52 % | $ 4.79 B | NYSE | ||
|
ResMed
RMD
|
$ 258.94 | 0.22 % | $ 37.8 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 18.29 | 1.89 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.68 | -3.05 % | $ 20.4 M | NYSE American | ||
|
ICU Medical
ICUI
|
$ 142.18 | -0.34 % | $ 3.5 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.57 | 4.25 % | $ 198 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 501.88 | 0.9 % | $ 179 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 126.05 | 2.43 % | $ 7.02 M | Nasdaq Global Select Market,SPB | ||
|
STERIS plc
STE
|
$ 244.67 | 0.62 % | $ 24.1 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 119.41 | -2.24 % | $ 5.33 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 74.53 | -0.43 % | $ 4.41 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.17 | 0.99 % | $ 244 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 19.17 | 1.32 % | $ 950 M | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 250.46 | -0.3 % | $ 18.1 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.0 | 0.67 % | $ 223 M | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 48.51 | 2.1 % | $ 159 M | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.47 | 1.24 % | $ 2.69 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 2.22 | 3.74 % | $ 179 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 2.33 % | $ 23.1 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.